Skip to Main Content

Paper Details

Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL.
Blood Adv
13
2018
Author NameAffiliation
Michael BockmayrResearch Institute Children's Cancer Center Hamburg
Michael BockmayrUniversity Medical Center
Michael BockmayrInstitute of Pathology, Charite-Universitatsmedizin Berlin
Florian BeckLeibniz-Institut fur Analytische Wissenschaften (ISAS)
  • 1 - 4

Datasets

Release 1.2